Symptomatic uses of caffeine in patients with cancer.

J Palliat Care

Pain and Palliative Care Service, Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Published: June 2003

Download full-text PDF

Source

Publication Analysis

Top Keywords

symptomatic caffeine
4
caffeine patients
4
patients cancer
4
symptomatic
1
patients
1
cancer
1

Similar Publications

With an incidence of 2-5 per million adults, cerebral venous and sinus thrombosis (CVST) is a rarity in the spectrum of cerebrovascular diseases. The etiology and symptomatic presentation are heterogeneous and diverse. CSVT is, therefore, often underdiagnosed.

View Article and Find Full Text PDF

Pneumocephalus is a rare but potentially serious complication of spinal procedures, characterized by the presence of intracranial air. This report presents the case of a 40-year-old female who developed pneumocephalus following a lumbar epidural steroid injection. She presented to the emergency department with a persistent headache, blurred vision, and eye pain, which began shortly after the procedure.

View Article and Find Full Text PDF

Plasma, brain and spinal cord concentrations of caffeine are reduced in the SOD1 mouse model of amyotrophic lateral sclerosis following oral administration.

Eur J Pharm Biopharm

October 2024

Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia. Electronic address:

Article Synopsis
  • Modifications to the small intestine and liver during ALS may affect drug absorption, particularly for caffeine, leading to reduced systemic and brain exposure.
  • Model drugs were tested on SOD1 mice (ALS model) and wild-type mice to compare pharmacokinetics and intestinal transport mechanisms.
  • Results showed that caffeine had significantly lower absorption in SOD1 mice, linked to slower gastric emptying and lower intestinal permeability, suggesting dosage adjustments for ALS patients may be necessary.
View Article and Find Full Text PDF

Introduction: Malignant hyperthermia (MH) is a potentially life-threatening pharmacogenetic syndrome triggered by volatile anaesthetics, succinylcholine, and stress such as vigorous exercise.

Case Presentation: The authors describe a case of an 8-year-old male who presented with classical symptoms of MH after induction of general anaesthesia and symptomatic treatment was done successfully due to the unavailability of Dantrolene.

Discussion: Definitive diagnosis of MH can be done based on a contracture test in fresh muscle biopsy in the presence of halothane and caffeine.

View Article and Find Full Text PDF

The Plasma Metabolome and Risk of Incident Kidney Stones.

J Am Soc Nephrol

October 2024

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Article Synopsis
  • - The study examines the link between plasma metabolomic profiles and the risk of developing kidney stones, revealing that information in this area is currently scarce.
  • - Three specific metabolites, including cryptoxanthin and two types of sphingomyelin, showed negative associations with the occurrence of kidney stones in both studied cohorts.
  • - The research involved a large sample size of 1,758 participants and used advanced statistical methods to assess the relationships between various metabolites and kidney stone formation risk.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!